Table 4.
Analysis of association of TGM2 polymorphism (rs4811528) with the development of DS in APL patients
| Model | Genotype | DS (%) | No DS (%) | OR (95% CI) | P-value | AIC | BIC |
|---|---|---|---|---|---|---|---|
| Codominant | A/A | 13 (72.2) | 37 (32.2) | 1.00 | 0.0096 | 90.2 | 104.7 |
| A/G | 4 (22.2) | 54 (47) | 5.61 (1.53–20.48) | ||||
| G/G | 1 (5.6) | 24 (20.9) | 6.14 (0.70–53.45) | ||||
| Dominant | A/A | 13 (72.2) | 37 (32.2) | 1.00 | 0.0023 | 88.2 | 99.8 |
| A/G-G/G | 5 (27.8) | 78 (67.8) | 5.72 (1.74–18.81) | ||||
| Recessive | A/A-A/G | 17 (94.4) | 91 (79.1) | 1.00 | 0.24 | 96.2 | 107.7 |
| G/G | 1 (5.6) | 24 (20.9) | 3.03 (0.36–25.25) | ||||
| Over dominant | A/A-G/G | 14 (77.8) | 61 (53) | 1.00 | 0.02 | 92.1 | 103.6 |
| A/G | 4 (22.2) | 54 (47) | 4.06 (1.14–14.44) | ||||
| Log-additive | – | – | – | 3.78 (1.37–10.44) | 0.004 | 89.2 | 100.8 |
AIC Akaike Information criterion, BIC Bayesian Information